Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

HIV & AIDS Health Center

Font Size

No AIDS Vaccines on the Near Horizon

WebMD Health News

Nov. 29, 1999 (Philadelphia) -- Vaccination against AIDS is still years away, so a primary focus of research is still treatment, according to investigators who spoke here recently at the 37th Annual Meeting of the Infectious Diseases Society of America (IDSA).

Neal Nathanson, MD, presented reasons why developing an AIDS vaccine is more complex than developing vaccines for other viruses. "It's going to be a long time [before an AIDS vaccine] is developed," he tells WebMD. "Clinical trials are extremely slow to do compared to efficacy trials of other vaccines. It really takes three to five years to do a trial of an AIDS vaccine. ... The best time frame we're looking at is 10 years, and it could be longer." Nathanson is director of the office of AIDS research at the National Institutes of Health.

According to Nathanson, there are several problems associated with developing an AIDS vaccine. For instance, it is hard to find antibodies that will completely neutralize or destroy HIV. Suppressing viral levels below a certain critical point during the initial phase of a viral infection is how most viral vaccines work; they don't kill the entire virus, but just enough to make it ineffective.

In HIV, however, such a vaccine would offer little or no protection against any remaining infection because the infection typically leads to continued drops in the number of all-important immune cells called CD4 cells. Eventual fatality from opportunistic infections or other complications will ultimately result when enough of those immune cells are destroyed.

In addition, vaccines that use a "live" form of HIV, much like some flu vaccines do, cannot be used because primate tests have shown that such a vaccine would, in and of itself, most likely eventually lead to full-blown AIDS. Targeting a combination of immune responses will probably be necessary to contain the virus.

Primate studies indicate that initial HIV exposure offers some, but not complete, protection against HIV reinfection, suggesting that a vaccine would similarly be able to offer only partial immunity. Therefore, the best case scenario for an AIDS vaccine would be one that keeps the virus at bay for a lifetime.

Today on WebMD

How much do you know?
contemplative man
What to do now.
Should you be tested?
HIV under microscope
What does it mean?
HIV AIDS Screening
man opening condom wrapper
HIV AIDS Treatment
Discrimination Stigma
Treatment Side Effects
grilled chicken and vegetables
obese man standing on scale
cold sore